BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10070237)

  • 1. [Prophylaxis of venous thromboembolism in medical patients: from medical decision tools to the use of low molecular weight heparin].
    Thilly N; Pierson H; Collard C; Lecompte T; Dufay E
    Therapie; 1998; 53(6):579-86. PubMed ID: 10070237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
    Villar Fernández I; Urbieta Sanz E; Arenere Mendoza M; López Larramona G; Marcilla Córdoba F; Rabanaque Hernández MJ
    Farm Hosp; 2004; 28(6):402-9. PubMed ID: 15628942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thromboembolic prophylaxis in hospitalized medical patients].
    Braekkan S; Grimsgaard S; Hansen JB
    Tidsskr Nor Laegeforen; 2007 May; 127(9):1177-80. PubMed ID: 17479133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
    Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
    Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolic risk and its prevention in hospitalized medical patients.
    Haas SK
    Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of venous thromboembolism prophylaxis for surgical patients: a multicentre analysis of practice in Spain.
    Otero R; Uresandi F; Cayuela A; Blanquer J; Cabezudo MA; De Gregorio MA; Lobo JL; Nauffal D; Oribe M
    Eur J Surg; 2001 Mar; 167(3):163-7. PubMed ID: 11316398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows.
    Scaglione L; Piobbici M; Pagano E; Ballini L; Tamponi G; Ciccone G
    Haematologica; 2005 May; 90(5):678-84. PubMed ID: 15921383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of venous thrombosis: role of heparins].
    Wahl D; Lepaux DJ; Piquemal R; Frédéric M; Cayrol C; Lecompte T; Thibaut G
    Therapie; 1998; 53(6):575-8. PubMed ID: 10070236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
    Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
    Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rationalization of risk factors for venous thromboembolism in medical inpatients. A prospective study].
    Pottier P; Planchon B; Truchaud F; Pistorius MA; Furic I; Grolleau JY
    J Mal Vasc; 2000 Oct; 25(4):241-9. PubMed ID: 11060418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism prophylaxis in medical patients: future perspectives.
    Imberti D; Prisco D
    Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S
    Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practice].
    Hirmerová J
    Vnitr Lek; 2006 Apr; 52(4):379-88. PubMed ID: 16755994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of venous thromboembolism in internal medicine and neurology].
    Malý J; Dulícek P; Penka M; Malý R; Gumulec J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.